B Cell Maturation Antigen Targeted Therapy and Forecast Market

List of Tables
Table 1. B Cell Maturation Antigen Targeted Therapy Market Opportunities & Trends in Global Market
Table 2. B Cell Maturation Antigen Targeted Therapy Market Drivers in Global Market
Table 3. B Cell Maturation Antigen Targeted Therapy Market Restraints in Global Market
Table 4. Key Players of B Cell Maturation Antigen Targeted Therapy in Global Market
Table 5. Top B Cell Maturation Antigen Targeted Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global B Cell Maturation Antigen Targeted Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global B Cell Maturation Antigen Targeted Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies B Cell Maturation Antigen Targeted Therapy Product Type
Table 9. List of Global Tier 1 B Cell Maturation Antigen Targeted Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 B Cell Maturation Antigen Targeted Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - B Cell Maturation Antigen Targeted Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - B Cell Maturation Antigen Targeted Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - B Cell Maturation Antigen Targeted Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - B Cell Maturation Antigen Targeted Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2024-2029
Table 30. GlaxoSmithKline Company Summary
Table 31. GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 32. GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. GlaxoSmithKline Key News & Latest Developments
Table 34. Johnson & Johnson Company Summary
Table 35. Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 36. Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Johnson & Johnson Key News & Latest Developments
Table 38. Amgen Company Summary
Table 39. Amgen B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 40. Amgen B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Amgen Key News & Latest Developments
Table 42. Seagen Company Summary
Table 43. Seagen B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 44. Seagen B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Seagen Key News & Latest Developments
Table 46. AbbVie Company Summary
Table 47. AbbVie B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 48. AbbVie B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. AbbVie Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 52. Novartis B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. BioTherapeutics Company Summary
Table 55. BioTherapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 56. BioTherapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. BioTherapeutics Key News & Latest Developments
Table 58. Celgene Company Summary
Table 59. Celgene B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 60. Celgene B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Celgene Key News & Latest Developments
Table 62. Bluebird Bio Company Summary
Table 63. Bluebird Bio B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 64. Bluebird Bio B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Bluebird Bio Key News & Latest Developments
Table 66. Bristol Mayer Squibb Company Summary
Table 67. Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 68. Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Bristol Mayer Squibb Key News & Latest Developments
Table 70. Carsgen Therapeutics Company Summary
Table 71. Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 72. Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Carsgen Therapeutics Key News & Latest Developments
Table 74. Juno Therapeutics Company Summary
Table 75. Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 76. Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Juno Therapeutics Key News & Latest Developments
Table 78. Cogent Bioscience Company Summary
Table 79. Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 80. Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. Cogent Bioscience Key News & Latest Developments
Table 82. CRISPR Therapeutics Company Summary
Table 83. CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 84. CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. CRISPR Therapeutics Key News & Latest Developments
Table 86. Allogene Therapeutics Company Summary
Table 87. Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 88. Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 89. Allogene Therapeutics Key News & Latest Developments
Table 90. Harpoon Therapeutics Company Summary
Table 91. Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 92. Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 93. Harpoon Therapeutics Key News & Latest Developments
Table 94. Poseida Therapeutics Company Summary
Table 95. Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 96. Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 97. Poseida Therapeutics Key News & Latest Developments
List of Figures
Figure 1. B Cell Maturation Antigen Targeted Therapy Segment by Type in 2022
Figure 2. B Cell Maturation Antigen Targeted Therapy Segment by Application in 2022
Figure 3. Global B Cell Maturation Antigen Targeted Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global B Cell Maturation Antigen Targeted Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by B Cell Maturation Antigen Targeted Therapy Revenue in 2022
Figure 8. By Type - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
Figure 16. US B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
Figure 20. Germany B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
Figure 28. China B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Amgen B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Seagen B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. AbbVie B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Novartis B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. BioTherapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Celgene B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bluebird Bio B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)